Dr Stephen Waters

Guest Contributor
March 16, 2009

Dr Stephen Waters has been appointed interim executive VP and chief scientific officer of DiaMedica Inc, Winnipeg, a developer of treatments for Type 2 diabetes. Walters replaces Dr Wayne Lautt, who discovered a key mechanism of insulin resistance that led to the founding of DiaMedica. A professor of pharmacology and therapeutics at the Univ of Manitoba, he is returning to basic research. Waters has held various senior positions with MGI Pharma and Ohmeda Pharmaceutical Products over a 24-year career. He holds an MSc in toxicology and PhD in pharmacology and toxicolo

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.